Back
Actinium Pharmaceuticals Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
25
ATNM
Actinium Pharmaceuticals
Last Price:
1.82
Seasonality Move:
4.44%
Buy
55
VRTX
Vertex Pharmaceuticals
Last Price:
464.85
Seasonality Move:
-0.92%
Sell
25
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $1.88. The Score for ATNM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $477.89. The Score for VRTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $1.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight buying pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $477.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
ATNM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 34.28 | Sell |
Chaikin Money Flow: | 63209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.8 - 2.04) | Sell |
Bollinger Bands (100): | (3.1 - 8.84) | Sell |
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.54 | Sell |
Relative Strength Index (14 RSI): | 48.75 | Sell |
Chaikin Money Flow: | -423811 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (472.82 - 487.82) | Sell |
Bollinger Bands (100): | (442.22 - 494.2) | Buy |
ATNM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.86 | Buy |
20-day SMA: | 1.89 | Sell |
50-day SMA: | 3.81 | Sell |
200-day SMA: | 6.24 | Sell |
8-day EMA: | 1.85 | Buy |
20-day EMA: | 2.08 | Sell |
50-day EMA: | 3.43 | Sell |
200-day EMA: | 5.82 | Sell |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 479.02 | Sell |
20-day SMA: | 479.85 | Sell |
50-day SMA: | 483.04 | Sell |
200-day SMA: | 439.9 | Buy |
8-day EMA: | 478.89 | Sell |
20-day EMA: | 479.27 | Sell |
50-day EMA: | 477.68 | Buy |
200-day EMA: | 440.79 | Buy |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.66 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $1.22 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Actinium Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vertex Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |